First Wave Biopharma

North America Legal Chronicle. March 21, 2024

First Wave BioPharma’s Acquisition of ImmunogenX

By Laura Testa

Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. October 9, 2023

First Wave Biopharma’s License Agreement with Sanofi for Capeserod

By Laura Testa

Lowenstein Sandler represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc., (NASDAQ:FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Synapticure’s $25 Million Series A Funding Round

Legendary Television’s Acquisition of Television Adaptation Rights of ‘Murdle’ Book

Minu’s $30 Million Funding Round

Grupo Pegasus’ Acquisition of Habitat Adulto Mayor

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

Trivela Group’s Acquisition of Silkeborg IF

Frigoglass Group’s €20 Million High Yield Notes Offering

The Exploration Company’s $160 Million Series B Financing Round

Landmark Developments’ Real Estate Financing

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Ministry of Finance of the People’s Republic of China (MOF)’s $2 Billion Sovereign Bond Issuance

Agro Tech Foods’ Acquisition of Del Monte Foods

Catbus Infolabs’ Bridge Financing Facilities

Hinshaw Adds Consumer Financial Services Partner Brian Turetsky in New York

Martim Della Valle is the new nominal partner of Marchini, Botelho e Caselta Advogados

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Hinshaw Adds Consumer Financial Services Partner Brian Turetsky in New York

Martim Della Valle is the new nominal partner of Marchini, Botelho e Caselta Advogados

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

First Wave BioPharma’s Acquisition of ImmunogenX

Standard 1 Year Membership Required

First Wave Biopharma’s License Agreement with Sanofi for Capeserod

Standard 1 Year Membership Required